Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
评价血枫丹滴丸治疗稳定性劳累型冠心病心绞痛(心血瘀阻证)安全性及有效性2b期临床试验
[Translation] Phase 2b clinical trial to evaluate the safety and efficacy of Xuefengdan dripping pills in the treatment of angina pectoris in stable exertional coronary heart disease (cardiac blood stasis syndrome)
评价血枫丹滴丸治疗稳定性劳累型冠心病心绞痛(心血瘀阻证)的安全性和有效性
[Translation] To evaluate the safety and efficacy of Xuefengdan dripping pills in the treatment of angina pectoris of stable exertional coronary heart disease (cardiac blood stasis syndrome)
100 Clinical Results associated with Shanghai Leyu Biological Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Leyu Biological Technology Co., Ltd.
100 Deals associated with Shanghai Leyu Biological Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Leyu Biological Technology Co., Ltd.